Movement Disorders (revue) - Exploration (Accueil)

Index « Mesh.i » - entrée « Oxidative Stress »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Oxidants < Oxidative Stress < Oxidopamine  Facettes :

List of bibliographic references indexed by Oxidative Stress

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000192 (2015) C Warren Olanow [États-Unis]Levodopa: effect on cell death and the natural history of Parkinson's disease.
000455 (2014) Nobutaka Hattori [Japon]REST as a new therapeutic target for neurodegenerative disorders.
000914 (2013) Amy W. Amara ; David G. StandaertMetabolomics and the Search for Parkinson Biomarkers
000B44 (2013) Peter A. Lewitt [États-Unis] ; Jia Li ; Mei Lu ; Thomas G. Beach ; Charles H. Adler ; Lining Guo3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis.
000B93 (2012) James T. Teo [Royaume-Uni] ; Mark J. Edwards ; Kailash BhatiaTardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis.
000E93 (2012) Kathleen M. Shannon [États-Unis] ; Ali Keshavarzian ; Ece Mutlu ; Hemraj B. Dodiya ; Delia Daian ; Jean A. Jaglin ; Jeffrey H. KordowerAlpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
001723 (2011) Thomas Müller [Allemagne] ; Siegfried Muhlack [Allemagne]Cysteinyl‐glycine reduction as marker for levodopa‐induced oxidative stress in Parkinson's disease patients
001D67 (2010) Mark R. Cookson [États-Unis]DJ‐1, PINK1, and their effects on mitochondrial pathways
002253 (2009) Satoru Morimoto [Japon] ; Shigeki Kuzuhara [Japon] ; Yasumasa Kokubo [Japon]Increased oxidative stress in patients with amyotrophic lateral sclerosis/Parkinsonism‐dementia complex in the Kii peninsula, Japan
002821 (2008) Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada]Glial reactions in Parkinson's disease
002987 (2008) Hiroyuki Soma [Japon] ; Ichiro Yabe [Japon] ; Asako Takei [Japon] ; Naoto Fujiki [Japon] ; Tetsuro Yanagihara [Japon] ; Hidenao Sasaki [Japon]Associations between multiple system atrophy and polymorphisms of SLC1A4, SQSTM1, and EIF4EBP1 Genes
002B32 (2007) C. Warren Olanow [États-Unis]The pathogenesis of cell death in Parkinson's disease – 2007
003221 (2006) Shin-Ichiro Kubo [Japon] ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon]Recessive Parkinson's disease
003311 (2006) Thanh G. Ton [États-Unis] ; Susan R. Heckbert [États-Unis] ; W. T. Longstreth Jr. [États-Unis] ; Mary Anne Rossing [États-Unis] ; Walter A. Kukull [États-Unis] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; Terri Smith-Weller [États-Unis] ; Harvey Checkoway [États-Unis]Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease
003888 (2005) Nadia Stefanova [Autriche] ; Markus Reindl [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]In vitro models of multiple system atrophy
003988 (2005) J. Eric Ahlskog [États-Unis]Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease
004026 (2003) Paul S. Fitzmaurice [Canada] ; Lee Ang [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada]Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease
004793 (2001) Federico M. Farin [États-Unis] ; Yolanda Hitosis [États-Unis] ; Sarah E. Hallagan [États-Unis] ; John Kushleika [États-Unis] ; James S. Woods [États-Unis] ; Patricia S. Janssen [États-Unis] ; Terri Smith-Weller [États-Unis] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; Harvey Checkoway [États-Unis]Genetic polymorphisms of superoxide dismutase in Parkinson's disease
004A44 (2000) Silvio Aime [Italie] ; Bruno Bergamasco [Italie] ; Mariano Casu [Italie] ; Giuseppe Digilio [Italie] ; Mauro Fasano [Italie] ; Sabrina Giraudo [Italie] ; Leonardo Lopiano [Italie]Isolation and 13C‐NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with parkinson's disease
004C23 (1999) Ann E. Kingsbury [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; Oliver J. F. Foster [Royaume-Uni]The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: An in situ hybridization study
004E08 (1999) Edna Grünblatt [Israël] ; Silvia Mandel [Israël] ; Tamara Berkuzki [Israël] ; M. B. H. Youdim [Israël]Apomorphine protects against MPTP‐induced neurotoxicity in mice

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Oxidative Stress" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Oxidative Stress" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Oxidative Stress
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024